AURX — Nuo Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $35.39m
- $34.46m
- $0.61m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.02 | 0.161 | 1.41 | 2.05 | 0.929 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | — | 0.092 | 0.251 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.277 | 0.161 | 1.47 | 2.63 | 1.56 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0 | 0 | 0 | 0.412 | 0.314 |
Total Assets | 0.277 | 0.161 | 1.47 | 3.05 | 1.88 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.49 | 0.665 | 0.673 | 0.6 | 0.675 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.49 | 0.665 | 0.673 | 0.856 | 0.839 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -1.21 | -0.504 | 0.793 | 2.19 | 1.04 |
Total Liabilities & Shareholders' Equity | 0.277 | 0.161 | 1.47 | 3.05 | 1.88 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |